INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 30.60 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 30.60K shares, a 82.91% decline from fiscal 2024.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 179.02K shares, a 148.64% increase from fiscal 2023.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 72.00K shares, a 50.57% decline from fiscal 2022.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 145.67K shares, a 73.55% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|
| 2025-12-31 | 30.60K shares 10-K · filed 2026-03-30 |
| 2024-12-31 | 179.02K shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 72.00K shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 145.67K shares 10-K · filed 2023-03-27 |
| 2021-12-31 | 550.77K shares 10-K · filed 2022-03-31 |